Efficacy and Safety of the Vasopressin V1A/V2-Receptor Antagonist Conivaptan in Acute Decompensated Heart Failure: A Dose-Ranging Pilot Study

  • Steven R. Goldsmith
  • , Uri Elkayam
  • , W. Herbert Haught
  • , Abhijit Barve
  • , Weizhong He

Research output: Contribution to journalArticlepeer-review

80 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and Safety of the Vasopressin V1A/V2-Receptor Antagonist Conivaptan in Acute Decompensated Heart Failure: A Dose-Ranging Pilot Study'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience